400 related articles for article (PubMed ID: 3278425)
21. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
[TBL] [Abstract][Full Text] [Related]
22. The influence of HLA matching in cardiac allograft recipients in a single center.
Raffoux C; Mayor V; Cabrol C; Busson M; Hors J; Colombani J
Transplant Proc; 1987 Oct; 19(5):3559-60. PubMed ID: 3313858
[No Abstract] [Full Text] [Related]
23. The influence on pretransplant blood transfusions from random donors on immune parameters affecting cadaveric allograft survival.
Kerman RH; Van Buren CT; Payne W; Flechner S; Agostino G; Conley S; Brewer E; Kahan BD
Transplantation; 1983 Jul; 36(1):50-4. PubMed ID: 6223421
[TBL] [Abstract][Full Text] [Related]
24. B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients.
Mahoney RJ; Taranto S; Edwards E
Hum Immunol; 2002 Apr; 63(4):324-35. PubMed ID: 12039415
[TBL] [Abstract][Full Text] [Related]
25. The influence of HLA-A,B and -DR matching on leucocyte infiltration in renal allografts.
McWhinnie DL; Fuggle SV; Thompson JF; Wood RF; Morris PJ
Tissue Antigens; 1987 Apr; 29(4):214-23. PubMed ID: 3303439
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
27. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
28. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
[TBL] [Abstract][Full Text] [Related]
29. Importance of HLA-DR matching in polytransfused cadaveric kidney transplant recipients. A prospective one-center study.
Vanrenterghem Y; Vandeputte I; Lerut T; Roels L; Gruwez J; Michielsen P
Transplantation; 1983 Oct; 36(4):384-7. PubMed ID: 6353705
[TBL] [Abstract][Full Text] [Related]
30. The changing role of HLA matching.
Cecka JM
Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
[TBL] [Abstract][Full Text] [Related]
31. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.
Martinelli GP; Chung-Loy R; Sher L; Racelis D; Miller CM; Schanzer H
Transplantation; 1985 Jan; 39(1):1-5. PubMed ID: 3880956
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH
Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103
[TBL] [Abstract][Full Text] [Related]
33. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
Lagaaij EL; Hennemann IP; Ruigrok M; de Haan MW; Persijn GG; Termijtelen A; Hendricks GF; Weimar W; Claas FH; van Rood JJ
N Engl J Med; 1989 Sep; 321(11):701-5. PubMed ID: 2671729
[TBL] [Abstract][Full Text] [Related]
34. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.
Lan JH; Kadatz M; Chang DT; Gill J; Gebel HM; Gill JS
Clin J Am Soc Nephrol; 2021 Feb; 16(2):275-283. PubMed ID: 33495290
[TBL] [Abstract][Full Text] [Related]
35. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
Oluwole SF; Lau HT; Reemtsma K; Hardy MA
Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
[TBL] [Abstract][Full Text] [Related]
36. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D
Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632
[No Abstract] [Full Text] [Related]
37. Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation.
Hiesse C; Busson M; Buisson C; Farahmand H; Bierling P; Benbunan M; Bedrossian J; Aubert P; Glotz D; Loirat C; Rondeau E; Viron B; Bleux H; Lang P
Kidney Int; 2001 Jul; 60(1):341-9. PubMed ID: 11422770
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
[TBL] [Abstract][Full Text] [Related]
39. The impact of HLA matching on graft survival and on sensitization after a failed transplant--evidence that failure of poorly matched renal transplants does not result in increased sensitization.
Matas AJ; Frey DJ; Gillingham KJ; Noreen HJ; Reinsmoen NL; Payne WD; Dunn DL; Sutherland DE; Najarian JS
Transplantation; 1990 Oct; 50(4):599-607. PubMed ID: 2219283
[TBL] [Abstract][Full Text] [Related]
40. Evidence that the difference in kidney graft survival in DRw6+ and DRw6- recipients may be explained by a blood transfusion policy that is disadvantageous for DRw6+ recipients.
Lagaaij EL; Persijn GG; Termijtelen A; Hendricks GF; de Lange P; van Rood JJ
Transplantation; 1987 Dec; 44(6):788-91. PubMed ID: 3321588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
